JP2020527396A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020527396A5 JP2020527396A5 JP2020501203A JP2020501203A JP2020527396A5 JP 2020527396 A5 JP2020527396 A5 JP 2020527396A5 JP 2020501203 A JP2020501203 A JP 2020501203A JP 2020501203 A JP2020501203 A JP 2020501203A JP 2020527396 A5 JP2020527396 A5 JP 2020527396A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- glucagon
- composition according
- patient
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023116382A JP2023156297A (ja) | 2017-07-14 | 2023-07-18 | 先天性高インスリン症を処置する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762532856P | 2017-07-14 | 2017-07-14 | |
| US62/532,856 | 2017-07-14 | ||
| PCT/US2018/042197 WO2019014658A1 (en) | 2017-07-14 | 2018-07-14 | METHODS OF TREATING CONGENITAL HYPERINSULINISM |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023116382A Division JP2023156297A (ja) | 2017-07-14 | 2023-07-18 | 先天性高インスリン症を処置する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020527396A JP2020527396A (ja) | 2020-09-10 |
| JP2020527396A5 true JP2020527396A5 (https=) | 2021-08-19 |
Family
ID=63080536
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020501203A Withdrawn JP2020527396A (ja) | 2017-07-14 | 2018-07-14 | 先天性高インスリン症を処置する方法 |
| JP2023116382A Pending JP2023156297A (ja) | 2017-07-14 | 2023-07-18 | 先天性高インスリン症を処置する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023116382A Pending JP2023156297A (ja) | 2017-07-14 | 2023-07-18 | 先天性高インスリン症を処置する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20200147306A1 (https=) |
| EP (1) | EP3651788A1 (https=) |
| JP (2) | JP2020527396A (https=) |
| KR (1) | KR20200029019A (https=) |
| CN (1) | CN110913888A (https=) |
| AU (1) | AU2018301715B2 (https=) |
| BR (1) | BR112020000447A2 (https=) |
| CA (1) | CA3069533A1 (https=) |
| CO (1) | CO2020000529A2 (https=) |
| IL (1) | IL271967A (https=) |
| MX (1) | MX2020000514A (https=) |
| WO (1) | WO2019014658A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020000447A2 (pt) * | 2017-07-14 | 2020-07-21 | Xeris Pharmaceuticals, Inc. | métodos de tratamento de hiperinsulinismo congênito |
| CN115916153A (zh) | 2020-06-26 | 2023-04-04 | Xeris药物公司 | 非质子极性溶剂中的稳定缓释治疗性组合物及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070029276A (ko) * | 2004-06-29 | 2007-03-13 | 디오벡스, 인코포레이티드 | 인슐린으로 인한 저혈당증을 예방하고 조절하기 위한조성물 및 방법 |
| WO2011031351A1 (en) | 2009-09-14 | 2011-03-17 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
| US8636711B2 (en) | 2010-06-14 | 2014-01-28 | Legacy Emanuel Hospital & Health Center | Stabilized glucagon solutions and uses therefor |
| IN2015DN00544A (https=) * | 2012-07-23 | 2015-06-26 | Zealand Pharma As | |
| WO2016196976A1 (en) * | 2015-06-04 | 2016-12-08 | Xeris Pharmaceuticals, Inc. | Glucagon delivery apparatuses and related methods |
| US9649364B2 (en) | 2015-09-25 | 2017-05-16 | Xeris Pharmaceuticals, Inc. | Methods for producing stable therapeutic formulations in aprotic polar solvents |
| EP3307295A1 (en) * | 2015-06-10 | 2018-04-18 | Xeris Pharmaceuticals, Inc. | Use of low dose glucagon |
| BR112020000447A2 (pt) * | 2017-07-14 | 2020-07-21 | Xeris Pharmaceuticals, Inc. | métodos de tratamento de hiperinsulinismo congênito |
-
2018
- 2018-07-14 BR BR112020000447-2A patent/BR112020000447A2/pt not_active IP Right Cessation
- 2018-07-14 EP EP18749686.4A patent/EP3651788A1/en active Pending
- 2018-07-14 MX MX2020000514A patent/MX2020000514A/es unknown
- 2018-07-14 AU AU2018301715A patent/AU2018301715B2/en active Active
- 2018-07-14 CA CA3069533A patent/CA3069533A1/en active Pending
- 2018-07-14 KR KR1020207004452A patent/KR20200029019A/ko not_active Ceased
- 2018-07-14 WO PCT/US2018/042197 patent/WO2019014658A1/en not_active Ceased
- 2018-07-14 JP JP2020501203A patent/JP2020527396A/ja not_active Withdrawn
- 2018-07-14 US US16/630,774 patent/US20200147306A1/en active Pending
- 2018-07-14 CN CN201880047057.3A patent/CN110913888A/zh active Pending
-
2020
- 2020-01-12 IL IL271967A patent/IL271967A/en unknown
- 2020-01-17 CO CONC2020/0000529A patent/CO2020000529A2/es unknown
-
2023
- 2023-07-18 JP JP2023116382A patent/JP2023156297A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108135980B (zh) | 在非质子极性溶剂中制备稳定的胰高血糖素治疗制剂的方法 | |
| JP5894174B2 (ja) | グルカゴンを含む新規組成物 | |
| JPH0367056B2 (https=) | ||
| US9192672B2 (en) | Zwitterion solution for low-volume therapeutic delivery | |
| WO2001052937A1 (en) | Mixed buffer system for stabilizing polypeptide formulations | |
| FI3506886T3 (fi) | Erittäin väkevöityjä alhaisen viskositeetin masp-2:ta estäviä vasta-aineformulaatioita, tarvikesarjoja ja menetelmiä | |
| WO2015059302A1 (en) | Stable formulation of insulin glulisine | |
| CA2995392C (en) | Stabilized glucagon solutions | |
| JP2021511386A5 (https=) | ||
| JP2020527396A5 (https=) | ||
| CN102421426A (zh) | 肠胃外给药的对乙酰氨基酚 | |
| JP2023156297A (ja) | 先天性高インスリン症を処置する方法 | |
| US9956287B2 (en) | Stable glucagon formulations | |
| US20070155768A1 (en) | Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same | |
| US20170202926A1 (en) | Parenteral Glucagon Formulations | |
| JPH10508598A (ja) | トロンビン阻害剤を含有する貯蔵安定な輸液用水溶液 | |
| US9155695B2 (en) | Injectable ropinirole compositions and methods for making and using same | |
| KR20220066317A (ko) | 피하 주사가능 인슐린 제제 및 투여 방법 | |
| JP2013520480A (ja) | 第ｉｘ因子の安定組成物 | |
| HK40081665A (en) | Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents | |
| HK40101667B (en) | Methods for producing stable therapeutic formulations in aprotic polar solvents | |
| HK40025146A (en) | Methods for treating congenital hyperinsulinism | |
| WO2017221026A1 (en) | Novel composition |